血管肉瘤治疗市场－全球产业规模、份额、趋势、机会和预测，按类型、治疗方法、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球血管肉瘤治疗市场规模为2.8011亿美元，预计到2030年将以6.11%的复合年增长率增长至3.9985亿美元。血管肉瘤治疗涵盖一系列治疗策略，包括手术、放射疗法、化疗和标靶药物疗法，这些疗法在各种医疗机构中均有应用，用于治疗这种侵袭性强且罕见的癌症。市场扩张的根本驱动力是全球血管肉瘤病例的不断增加，这促使人们需要更先进的治疗方法。

主要市场驱动因素

全球血管肉瘤治疗市场受到血管肉瘤发生率上升的显着影响。这种侵袭性强的罕见癌症发生率显着增加，从而扩大了需要治疗干预的患者群体。

主要市场挑战

全球血管肉瘤治疗市场扩张的一大障碍是缺乏标准化的治疗方案。血管肉瘤本身的罕见性和异质性导致缺乏普遍接受的临床指南，造成不同医疗机构间患者治疗方案有显着差异。

主要市场趋势

免疫疗法的应用日益广泛，是全球血管肉瘤治疗市场的一大趋势，它利用患者自身的免疫系统对抗癌症。对于血管肉瘤这类侵袭性强、罕见的癌症，传统疗法往往疗效有限，因此免疫疗法至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球血管肉瘤治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（血管肉瘤、淋巴管肉瘤、实质血管肉瘤）
  • 依治疗方法（手术、放射线治疗、化学疗法、标靶治疗、免疫疗法、其他）
  • 依最终使用者（医院和诊所、门诊手术中心、线上药局）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美血管肉瘤治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲血管肉瘤治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区血管肉瘤治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲血管肉瘤治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲血管肉瘤治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球血管肉瘤治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Novartis AG
• Bayer AG
• Sanofi AG
• Amgen Inc
• Eli Lilly and Company
• Genentech Inc.
• Janssen Pharmaceuticals
• AbbVie Inc
• Bausch Health Companies Inc.
• GlaxoSmithKline Plc

第十六章：策略建议

第17章调查会社について・免责事项

The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a range of therapeutic strategies, including surgery, radiation therapy, chemotherapy, and targeted drug therapies, employed across various healthcare settings to manage this aggressive and rare cancer. The market's expansion is fundamentally driven by the increasing incidence of angiosarcoma cases globally, necessitating advanced therapeutic interventions.

Key Market Drivers

The global angiosarcoma treatment market is significantly influenced by the rising incidence of angiosarcoma cases. This aggressive rare cancer has demonstrated a notable increase in its occurrence, thereby expanding the patient population requiring therapeutic intervention. According to a study published in JAMA Network Open in April 2024, the U. S. incidence of angiosarcoma doubled from 657 newly diagnosed cases in 2001 to 1312 cases in 2019.

Key Market Challenges

A significant impediment to the expansion of the Global Angiosarcoma Treatment Market is the persistent lack of standardized treatment protocols. The inherent rarity and heterogeneous nature of angiosarcoma contribute to an absence of universally accepted clinical guidelines, resulting in considerable variability in patient care across institutions. This inconsistency directly hampers the development and adoption of advanced therapeutic interventions.

Key Market Trends

The expanding application of immunotherapy is a significant trend in the global angiosarcoma treatment market, leveraging the patient's immune system against cancer. This approach is vital for aggressive, rare cancers like angiosarcoma, where traditional therapies often have limited success. Research into tumor immunology has advanced, leading to innovative immune checkpoint inhibitors.

Key Market Players

• Novartis AG
• Bayer AG
• Sanofi AG
• Amgen Inc
• Eli Lilly and Company
• Genentech Inc.
• Janssen Pharmaceuticals
• AbbVie Inc
• Bausch Health Companies Inc.
• GlaxoSmithKline Plc

Report Scope:

In this report, the Global Angiosarcoma Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Angiosarcoma Treatment Market , By Type:

• Hemangiosarcoma
• Lymphangiosarcoma
• Parenchymal Angiosarcoma

Angiosarcoma Treatment Market , By Treatment:

• Surgery
• Radiotherapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Others

Angiosarcoma Treatment Market , By End user:

• Hospital & Clinics
• Ambulatory Surgical Centers
• Online Pharmacies

Angiosarcoma Treatment Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Angiosarcoma Treatment Market .

Available Customizations:

Global Angiosarcoma Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Angiosarcoma Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma)
  • 5.2.2. By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others)
  • 5.2.3. By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Angiosarcoma Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Treatment
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Angiosarcoma Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Treatment
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Angiosarcoma Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Treatment
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Angiosarcoma Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Treatment
      • 6.3.3.2.3. By End user

7. Europe Angiosarcoma Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Treatment
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Angiosarcoma Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Treatment
      • 7.3.1.2.3. By End user
  • 7.3.2. France Angiosarcoma Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Treatment
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Angiosarcoma Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Treatment
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Angiosarcoma Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Treatment
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Angiosarcoma Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Treatment
      • 7.3.5.2.3. By End user

8. Asia Pacific Angiosarcoma Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Treatment
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Angiosarcoma Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Treatment
      • 8.3.1.2.3. By End user
  • 8.3.2. India Angiosarcoma Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Treatment
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Angiosarcoma Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Treatment
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Angiosarcoma Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Treatment
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Angiosarcoma Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Treatment
      • 8.3.5.2.3. By End user

9. Middle East & Africa Angiosarcoma Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Treatment
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Angiosarcoma Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Treatment
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Angiosarcoma Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Treatment
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Angiosarcoma Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Treatment
      • 9.3.3.2.3. By End user

10. South America Angiosarcoma Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Treatment
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Angiosarcoma Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Treatment
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Angiosarcoma Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Treatment
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Angiosarcoma Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Treatment
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Angiosarcoma Treatment Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novartis AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. Sanofi AG
• 15.4. Amgen Inc
• 15.5. Eli Lilly and Company
• 15.6. Genentech Inc.
• 15.7. Janssen Pharmaceuticals
• 15.8. AbbVie Inc
• 15.9. Bausch Health Companies Inc.
• 15.10. GlaxoSmithKline Plc

16. Strategic Recommendations

17. About Us & Disclaimer